FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2046991618> ?p ?o ?g. }

• W2046991618 endingPage "140" @default.
• W2046991618 startingPage "131" @default.
• W2046991618 abstract "Lafora disease (LD) is an autosomal recessive, always fatal progressive myoclonus epilepsy with rapid cognitive and neurologic deterioration. One of the pathological hallmarks of LD is the presence of cytoplasmic PAS+polyglucosan inclusions called Lafora bodies (LBs). Current clinical and neuropathological views consider LBs to be the cause of neurological derangement of patients. A systematic study of the ontogeny and structural features of the LBs has not been done in the past. Therefore, we undertook a detailed microscopic analysis of the neuropile of a Laforin-deficient (epm2a-/-) mouse model. Wild type and epm2a-/- mice were sacrificed at different ages and their encephalon processed for light microscopy. Luxol-fast-blue, PAS, Bielschowski techniques, as well as immunocytochemistry (TUNEL, Caspase-3, Apaf-1, Cytochrome-C and Neurofilament L antibodies) were used. Young null mice (11 days old) showed necrotic neuronal death in the absence of LBs. Both cell death and LBs showed a progressive increment in size and number with age. Type I LBs emerged at two weeks of age and were distributed in somata and neurites. Type II LBs appeared around the second month of age and always showed a complex architecture and restricted to neuronal somata. Their number was considerably less than type I LBs. Bielschowski method showed neurofibrillary degeneration and senile-like plaques. These changes were more prominent in the hippocampus and ventral pons. Neurofibrillary tangles were already present in 11 days-old experimental animals, whereas senile-like plaques appeared around the third to fourth month of life. The encephalon of null mice was not uniformly affected: Diencephalic structures were spared, whereas cerebral cortex, basal ganglia, pons, hippocampus and cerebellum were notoriously affected. This uneven distribution was present even within the same structure, i.e., hippocampal sectors. Of special relevance, was the observation of the presence of immunoreactivity to neurofilament L on the external rim of type II LBs. Perhaps, type II LB is not the end point of a metabolic abnormality. Instead, we suggest that type II LB is a highly specialized structural and functional entity that emerges as a neuronal response to major carbohydrate metabolism impairment. Early necrotic cell death, neurocytoskeleton derangement, different structural and probably functional profiles for both forms of LBs, a potential relationship between the external rim of the LB type II and the cytoskeleton and an uneven distribution of these abnormalities indicate that LD is both a complex neurodegenerative disease and a glycogen metabolism disorder. Our findings are critical for future studies on disease mechanisms and therapies for LD. Interestingly, the neurodegenerative changes observed in this LD model can also be useful for understanding the process of dementia." @default.
• W2046991618 created "2016-06-24" @default.
• W2046991618 creator A5002324943 @default.
• W2046991618 creator A5002881249 @default.
• W2046991618 creator A5026317578 @default.
• W2046991618 creator A5027539533 @default.
• W2046991618 creator A5037228827 @default.
• W2046991618 creator A5048002225 @default.
• W2046991618 creator A5055970219 @default.
• W2046991618 creator A5074948910 @default.
• W2046991618 creator A5086570255 @default.
• W2046991618 date "2012-07-01" @default.
• W2046991618 modified "2023-10-18" @default.
• W2046991618 title "Ontogeny of Lafora bodies and neurocytoskeleton changes in Laforin-deficient mice" @default.
• W2046991618 cites W1562206355 @default.
• W2046991618 cites W1584056801 @default.
• W2046991618 cites W1820664268 @default.
• W2046991618 cites W1965827383 @default.
• W2046991618 cites W1965869435 @default.
• W2046991618 cites W1967024359 @default.
• W2046991618 cites W1990931216 @default.
• W2046991618 cites W1994475975 @default.
• W2046991618 cites W1996694498 @default.
• W2046991618 cites W2008871433 @default.
• W2046991618 cites W2010595874 @default.
• W2046991618 cites W2021901516 @default.
• W2046991618 cites W2023272535 @default.
• W2046991618 cites W2025046694 @default.
• W2046991618 cites W2031179697 @default.
• W2046991618 cites W2031212282 @default.
• W2046991618 cites W2039257448 @default.
• W2046991618 cites W2050545428 @default.
• W2046991618 cites W2062644904 @default.
• W2046991618 cites W2070907454 @default.
• W2046991618 cites W2071844030 @default.
• W2046991618 cites W2074906210 @default.
• W2046991618 cites W2084008782 @default.
• W2046991618 cites W2102873804 @default.
• W2046991618 cites W2104410524 @default.
• W2046991618 cites W2114440563 @default.
• W2046991618 cites W2118393368 @default.
• W2046991618 cites W2131518907 @default.
• W2046991618 cites W2137181909 @default.
• W2046991618 cites W2140357048 @default.
• W2046991618 cites W2144496034 @default.
• W2046991618 cites W2145843041 @default.
• W2046991618 cites W2153703070 @default.
• W2046991618 cites W2165372472 @default.
• W2046991618 cites W2170294600 @default.
• W2046991618 cites W2171666662 @default.
• W2046991618 cites W2247094800 @default.
• W2046991618 cites W2411262547 @default.
• W2046991618 cites W2886609134 @default.
• W2046991618 cites W2887839844 @default.
• W2046991618 doi "https://doi.org/10.1016/j.expneurol.2012.04.008" @default.
• W2046991618 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3367664" @default.
• W2046991618 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22542948" @default.
• W2046991618 hasPublicationYear "2012" @default.
• W2046991618 type Work @default.
• W2046991618 sameAs 2046991618 @default.
• W2046991618 citedByCount "18" @default.
• W2046991618 countsByYear W20469916182013 @default.
• W2046991618 countsByYear W20469916182014 @default.
• W2046991618 countsByYear W20469916182017 @default.
• W2046991618 countsByYear W20469916182018 @default.
• W2046991618 countsByYear W20469916182019 @default.
• W2046991618 countsByYear W20469916182020 @default.
• W2046991618 countsByYear W20469916182021 @default.
• W2046991618 countsByYear W20469916182022 @default.
• W2046991618 countsByYear W20469916182023 @default.
• W2046991618 crossrefType "journal-article" @default.
• W2046991618 hasAuthorship W2046991618A5002324943 @default.
• W2046991618 hasAuthorship W2046991618A5002881249 @default.
• W2046991618 hasAuthorship W2046991618A5026317578 @default.
• W2046991618 hasAuthorship W2046991618A5027539533 @default.
• W2046991618 hasAuthorship W2046991618A5037228827 @default.
• W2046991618 hasAuthorship W2046991618A5048002225 @default.
• W2046991618 hasAuthorship W2046991618A5055970219 @default.
• W2046991618 hasAuthorship W2046991618A5074948910 @default.
• W2046991618 hasAuthorship W2046991618A5086570255 @default.
• W2046991618 hasBestOaLocation W20469916182 @default.
• W2046991618 hasConcept C11960822 @default.
• W2046991618 hasConcept C142724271 @default.
• W2046991618 hasConcept C148762608 @default.
• W2046991618 hasConcept C157207234 @default.
• W2046991618 hasConcept C169760540 @default.
• W2046991618 hasConcept C178666793 @default.
• W2046991618 hasConcept C204232928 @default.
• W2046991618 hasConcept C2776538686 @default.
• W2046991618 hasConcept C2777280662 @default.
• W2046991618 hasConcept C2779134260 @default.
• W2046991618 hasConcept C2781161787 @default.
• W2046991618 hasConcept C502032728 @default.
• W2046991618 hasConcept C68026918 @default.
• W2046991618 hasConcept C71924100 @default.
• W2046991618 hasConcept C86803240 @default.
• W2046991618 hasConcept C95444343 @default.
• W2046991618 hasConceptScore W2046991618C11960822 @default.

• next